Autolus Therapeutics (AUTL) vs Electra Therapeutics (ETRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Electra Therapeutics is the larger company by market cap ($575.6 million vs $465.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AUTL | ETRA |
|---|---|---|
| Share price | $1.75 | $9.17 |
| Market cap | $465.60M | $575.57M |
| 1-day change | -1.17% | +0.33% |
| YTD return | -11.06% | — |
| 1-year return | +0.57% | — |
| 5-year return | -71.17% | — |
| EPS (TTM) | $-1.06 | $-2.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.58 | $15.50 |
| 52-week low | $1.18 | $8.63 |
| Distance from 52-week high | -32.20% | -40.84% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +399.06% | — |
| Average volume | 2.10M | 912.83K |
| Shares outstanding | 266.16M | 62.77M |
| Employees | 752 | 46 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Autolus Therapeutics
AUTL stock →Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally. The company offers AUCATZYL, a gene therapy product consisting of autologous T cells that are transduced with a lentiviral vector to express a novel anti-CD19 chimeric antigen receptor.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 752 employees
About Electra Therapeutics
ETRA stock →Electra Therapeutics, Inc. is a clinical-stage biotechnology company.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 46 employees
AUTL vs ETRA FAQ
Which is bigger, Autolus Therapeutics or Electra Therapeutics?
Electra Therapeutics (ETRA) is larger, with a market capitalization of $575.57M compared with $465.60M for Autolus Therapeutics (AUTL).
Are Autolus Therapeutics and Electra Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.